Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,707 | 60,009 | 81,527 | 0 | N/A |
| Marketable Securities | N/A | 39,994 | N/A | 0 | N/A |
| Receivables | 132 | N/A | N/A | 0 | N/A |
| TOTAL | $46,905 | $104,390 | $83,252 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 420 | 626 | 463 | 0 | N/A |
| Other Non-Current Assets | 12 | 137 | 137 | 0 | 0 |
| TOTAL | $432 | $763 | $600 | $N/A | $N/A |
| Total Assets | $47,337 | $105,153 | $83,852 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,027 | 3,710 | 5,517 | 0 | 0 |
| Accrued Expenses | 5,777 | 5,820 | 3,925 | 0 | N/A |
| Other current liabilities | N/A | 20 | 12,029 | 0 | N/A |
| TOTAL | $10,259 | $10,338 | $25,378 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 455 | 788 | 3,907 | N/A | N/A |
| Other Non-Current Liabilities | 114 | 19 | 44 | 0 | 0 |
| TOTAL | $13,456 | $13,915 | $15,465 | $N/A | $N/A |
| Total Liabilities | $23,715 | $24,253 | $40,843 | $0 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 217 | 215 | 26 | 0 | N/A |
| Retained earnings | -294,578 | -230,896 | -168,353 | 0 | N/A |
| Other shareholders' equity | 861 | 488 | 201,315 | 0 | 0 |
| TOTAL | $23,622 | $80,900 | $43,009 | $0 | $N/A |
| Total Liabilities And Equity | $47,337 | $105,153 | $83,852 | $0 | $0 |